Nov 16, 2023
Breakthrough in Ataxia Telangiectasia Treatment: The Power of Niagen®
This is an exciting news from the world of medical research!
In a remarkable development in the field of medical science, a recent Phase II clinical study has brought new hope to patients suffering from Ataxia Telangiectasia (AT), a rare neurodegenerative disorder. This study, involving ChromaDex's patented nicotinamide riboside (NR) ingredient, Niagen®, has shown promising results in improving the lives of those affected by AT. Learn here about key findings and more! If you are interested in the latest publications and events related to longevity, just click on the corresponding words, and you will be redirected to the associated web pages. Read the full article
#AtaxiaTelangiectasia#BiomedicalInnovation#ChromaDex#ClinicalStudyonAT#DNARepairandCellularEnergy#EyeMovementEnhancement#GeneticConditions#HealthyAgingResearch#MitochondrialFunction#MotorCoordinationImprovement#NAD+Supplementation#NeurodegenerativeDisorderTreatment#NeurologicalHealth#Niagen®#NicotinamideRiboside